EP. 1: Case 1: Optimal Induction Therapy for Myeloma
Watch
EP. 2: Case 1: Ineligibility for Transplant in Myeloma
EP. 3: Case 1: Molecular Testing in Myeloma
EP. 4: Case 1: Consolidation Therapy in Myeloma
EP. 5: Case 1: Transplant Eligibility in Myeloma
EP. 6: Case 2: The Role of Maintenance Therapy in Myeloma
EP. 7: Case 2: Molecular Risk Stratification in Myeloma
EP. 8: Case 2: MRD Negativity in High-Risk Myeloma
EP. 9: Case 2: Evolution of Molecular Testing in Myeloma
EP. 10: Case 3: Aggressive Relapse of Multiple Myeloma
EP. 11: Case 3: Molecular Testing in Relapsed Myeloma
EP. 12: Case 3: Treatment for Relapsed Myeloma with 17p Deletion
EP. 13: Case 4: CAR T-Cell Therapy for Heavily Pretreated Myeloma
EP. 14: Case 4: Molecular Testing and CAR T-Cell Therapy in Myeloma
EP. 15: Case 4: CAR T-Cell Therapy in Myeloma
EP. 16: Case 4: BCMA-Targeted CAR T-Cell Therapy in Myeloma
